Here are what the editors at HealthDay consider to be the most important developments in Dermatology for February 2017. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Strategies Suggested to Protect Practices From Hackers
TUESDAY, Feb. 28, 2017 (HealthDay News) — Steps should be taken to protect medical practices, including small practices, from hackers, according to a report published in Medical Economics.
Physician Burnout Eroding Sense of Calling
TUESDAY, Feb. 28, 2017 (HealthDay News) — For physicians across specialties, burnout is associated with reduced odds of a sense of calling, according to a study published online Feb. 8 in the Mayo Clinic Proceedings.
Supreme Court Rules Patient Safety Data Subject to Litigation
MONDAY, Feb. 27, 2017 (HealthDay News) — The Supreme Court of Florida has reversed a District Court of Appeal decision deeming information related to patient safety unprotected from litigation discovery, according to a report published from the American Medical Association.
Depressed Psoriasis Patients at Higher Risk of Psoriatic Arthritis
MONDAY, Feb. 27, 2017 (HealthDay News) — Patients with psoriasis who also have major depressive disorder may face a much higher risk for psoriatic arthritis, according to a study published online Feb. 22 in the Journal of Investigative Dermatology.
$20 Million Awarded for Quality Payment Program Training
FRIDAY, Feb. 24, 2017 (HealthDay News) — About $20 million has been awarded to 11 organizations for the first of a five-year program to provide training and education about the Quality Payment Program for clinicians in individual or small group practices, with up to $80 million to be invested over the remaining four years, according to the U.S. Centers for Medicare & Medicaid Services (CMS).
Large-Scale Skin Cancer Screening Initiative Feasible
FRIDAY, Feb. 24, 2017 (HealthDay News) — Large-scale skin cancer screening, including full-body skin examination (FBSE) is feasible and increases diagnosis of melanoma and thinner invasive melanoma, according to a study published online Feb. 23 in JAMA Oncology.
Cyberattacks Remain Serious Threat to Health Providers
THURSDAY, Feb. 23, 2017 (HealthDay News) — Cyberattacks remain a serious threat to small providers as well as big institutions, according to a report published in Medical Economics.
Health Information Theft a Pressing Concern for U.S. Patients
WEDNESDAY, Feb. 22, 2017 (HealthDay News) — Forty-four percent of U.S. adults are worried about having their personal health care information stolen, according to findings from the Xerox eHealth Survey published Feb. 9 in HIT Consultant.
CMS Rule Set to Stabilize Small Health Insurance Markets
TUESDAY, Feb. 21, 2017 (HealthDay News) — The U.S. Centers for Medicare & Medicaid Services (CMS) has proposed a rule in relation to new reforms intended to stabilize individual and small group health insurance markets for 2018.
Drug-Induced Lupus Seen With Adalimumab Treatment
MONDAY, Feb. 20, 2017 (HealthDay News) — In a case report published online Feb. 12 in the Journal of Clinical Pharmacy and Therapeutics, drug-induced lupus erythematosus (DILE) is described in a patient taking adalimumab for psoriasis.
Guidelines May Assist Optimal Outcomes in Lip Augmentation
FRIDAY, Feb. 17, 2017 (HealthDay News) — The most attractive lip surface area has been determined as representing a 53.5 percent increase from baseline, with an upper to lower lip ratio of 1:2, according to a study published online Feb. 16 in JAMA Facial Plastic Surgery.
Unipolar Radiofrequency Device Safe, Effective for Face Tightening
FRIDAY, Feb. 17, 2017 (HealthDay News) — For subjects with facial laxity, a novel fractional unipolar radiofrequency (RF) device is safe and efficacious for facial tightening, according to a study published online Feb. 13 in the Journal of Cosmetic Dermatology.
Health Care Spending Expected to Grow 5.6% Annually to 2025
THURSDAY, Feb. 16, 2017 (HealthDay News) — Health care spending is expected to grow at an average annual rate of 5.6 percent from 2016 to 2025, according to a report published online Feb. 15 in Health Affairs.
FDA Approves Siliq for Plaque Psoriasis
THURSDAY, Feb. 16, 2017 (HealthDay News) — The injected drug Siliq (brodalumab) has been approved by the U.S. Food and Drug Administration to treat moderate-to-severe plaque psoriasis in adults.
Dermoscopy + Triple Light Source Reliable in ID of Pityriasis Rosea
WEDNESDAY, Feb. 15, 2017 (HealthDay News) — Dermoscopy with three light sources is ideal for diagnosing pityriasis rosea (PR), according to a research letter published online Feb. 10 in the International Journal of Dermatology.
Full Text (subscription or payment may be required)
Nearly 300 Genetic Regions Linked to Male Pattern Baldness
TUESDAY, Feb. 14, 2017 (HealthDay News) — Close to 300 genetic regions tied to male pattern baldness have been identified, according to a study published online Feb. 14 in PLOS Genetics.
Full Text
Uptake of Topical Compounds Higher With Thermal Coagulation
TUESDAY, Feb. 14, 2017 (HealthDay News) — Microchannels surrounded by a coagulation zone (CZ), generated by ablative fractional laser, have higher uptake of topical compounds than those without a CZ, according to a study published online Feb. 9 in Lasers in Surgery and Medicine.
Full Text (subscription or payment may be required)
Fatigue Occurs in ~50 Percent With Chronic Plaque Psoriasis
TUESDAY, Feb. 14, 2017 (HealthDay News) — About half of patients with chronic plaque psoriasis have fatigue, according to a study published online Feb. 9 in the British Journal of Dermatology.
Full Text (subscription or payment may be required)
Orbital Cellulitis Reported After Use of Facial Soft-Tissue Filler
TUESDAY, Feb. 14, 2017 (HealthDay News) — Delayed and recurrent orbital cellulitis following use of facial soft-tissue filler is described in a case report published online Feb. 10 in Clinical & Experimental Ophthalmology.
Full Text (subscription or payment may be required)
Reduced Immune Response After Intradermal Flu Shot in Eczema
MONDAY, Feb. 13, 2017 (HealthDay News) — For patients with moderate/severe atopic dermatitis (AD), those colonized with Staphylococcus aureus have a reduced immune response to intradermal influenza vaccination, according to a study published online Feb. 13 in the Journal of Allergy and Clinical Immunology.
Full Text (subscription or payment may be required)
High-Energy Protocol Improves Photoaged Facial Skin
MONDAY, Feb. 13, 2017 (HealthDay News) — For patients with mild-to-moderate facial wrinkles, a high-energy protocol with combined bipolar radiofrequency and infrared light energies improves facial skin, according to a study published online Feb. 8 in the Journal of Cosmetic Dermatology.
Full Text (subscription or payment may be required)
Low Serum Zinc, Selenium May Be Risk Factors for Alopecia Areata
THURSDAY, Feb. 9, 2017 (HealthDay News) — Patients with alopecia areata (AA) have significantly lower serum levels of zinc and selenium, according to a meta-analysis published online Feb. 2 in The Journal of Dermatology.
Full Text (subscription or payment may be required)
Monophasic HA Filler + Lidocaine Corrects Nasolabial Folds
THURSDAY, Feb. 9, 2017 (HealthDay News) — The monophasic hyaluronic acid (HA) filler with lidocaine, Dermalax implant plus (PLUS), is not inferior to the biphasic HA Restylane Sub-Q (Sub-Q) for correcting nasolabial folds (NLFs), according to a study published online Feb. 1 in the Journal of Cosmetic Dermatology.
Full Text (subscription or payment may be required)
Variation in Prescribing Practices for Pediatric Atopic Dermatitis
MONDAY, Feb. 6, 2017 (HealthDay News) — Prescribing practices vary among U.S. and Canadian physicians treating severe childhood atopic dermatitis (AD), according to a study published in the February issue of the Journal of the American Academy of Dermatology.
Full Text (subscription or payment may be required)
Immunotherapy Better Than Cryotherapy for Wart Lesions
FRIDAY, Feb. 3, 2017 (HealthDay News) — Intralesional immunotherapy is more effective than cryotherapy for treatment of wart lesions, according to a study published online Jan. 21 in the International Journal of Dermatology.
Full Text (subscription or payment may be required)
Copyright © 2017 ScoutNews, LLC. All rights reserved.
